Drug intelligence / Profile preview

GEO MIGRA

Development stage: Preclinical
Lead developer: PlantEXT
Modality: Small Molecules
Administration: Topical

Overview

GEO MIGRA is a topical cream formulation developed by PlantEXT for the treatment of migraine pain. It is formulated with a combination of cannabidiol (CBD) and specific terpenes designed to act synergistically to alleviate pain and inflammation associated with migraines. The topical route of administration allows for localized delivery of the active ingredients to target areas, providing a non-invasive alternative to systemic migraine treatments.

Brand names: GEO MIGRA

Beyond the preview

Go deeper on GEO MIGRA.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on GEO MIGRA.

Explore the full profile